Management

1. Stop the clobetasol-luliconazole combination immediately and advise against any future steroid-antifungal fixed-dose combination on the face.
   • A flare of redness/papules can occur over the next few days after stopping, particularly if it was used repeatedly or for a prolonged period.
   • If there has been very prolonged use with severe rebound risk, withdrawal strategy should be decided by a dermatologist. Practice varies between abrupt cessation and a short supervised step-down approach.
2. Assess the morphology and distribution
   • Papules/pustules predominantly around mouth, nose or eyes with sparing of vermilion border suggests periorificial dermatitis.
   • Central facial erythema with papules/pustules, flushing or telangiectasia suggests steroid-induced rosacea-like dermatitis.
   • Monomorphic papules without comedones may indicate steroid acneiform eruption.
   • Do a KOH scraping from any scaly annular lesion before antifungal therapy, because steroid use can mask dermatophyte infection as tinea incognito.
3. Skin-care measures
   • Use only a bland, fragrance-free cleanser and non-comedogenic moisturizer.
   • Avoid scrubs, facials, makeup where possible, fairness creams, retinoids, benzoyl peroxide, and other irritating actives until settled.
   • Daily broad-spectrum sunscreen, preferably mineral-based if stinging occurs.
   • Do not use steroid creams on the face without dermatology advice.
4. Anti-inflammatory treatment, selected after examination
   • For mild localized disease: a dermatologist may use topical metronidazole, azelaic acid, or ivermectin. These can sting initially on steroid-damaged skin.
   • Pimecrolimus 1% cream or tacrolimus ointment can be useful during steroid withdrawal, particularly where periorificial dermatitis is prominent. Andrews notes that stopping topical corticosteroid is central, and tacrolimus/pimecrolimus may reduce flaring after withdrawal; topical/oral antibiotics and agents such as azelaic acid, ivermectin, and metronidazole may clear lesions (Andrews’ Diseases of the Skin, p. 296).
   • For moderate to severe widespread papulopustular disease: dermatology review for an oral tetracycline-class agent such as doxycycline is reasonable. Avoid tetracyclines in pregnancy and assess pregnancy status before prescribing.
5. Review in 2-4 weeks
   • Improvement is often gradual and may take weeks.
   • Refer earlier if there is marked facial swelling, extensive pustules/crusting, eye pain/redness/visual symptoms, suspected infection, diagnostic uncertainty, or no improvement after steroid withdrawal.